Denmark predicts new EU requirements following Dicillin scandal

The contamination of an antibiotic that infected Danish patients with multiresistant bacteria is such an unusual case it could lead to wide-reaching consequences, says the Danish Medicines Agency. 
Photo: Lægemiddelstyrelsen/pr
Photo: Lægemiddelstyrelsen/pr
by ulrich quistgaard, translated by daniel pedersen

The Dicillin scandal currently evolving in Denmark could lead to new EU requirements for drug making, says the Danish Medicines Agency.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading